Prioritizing Brain Health in the European Union: Closing the Treatment Gap [Promoted content]
Angelini Pharma’s CSO Rafal Kaminski, underscores the rising burden of brain diseases, advocating global attention to brain health. The Headway initiative is presented as a collaborative platform promoting harmonization programs and European guidelines…